Lars Schwettmann

Learn More
In 2011 and 2012 a change of rules and a data-manipulation scandal focused German public attention on organ donation. This increased citizens' background knowledge as well as their willingness to respond to surveys. The present study is an effort to seize this research opportunity and to create evidence on which policy recommendations can be conceivably(More)
In decisions on financing new and innovative health care technologies a central question is how to determine the value citizens place on the gains in health and life expectancy that result from respective medical treatments. We report results of surveys of four representative samples of the German population. In 2010 and 2012, in total about 5000(More)
FOR 655 Working Paper serves to disseminate the research results of work in progress prior to publication to encourage academic debate. Die Reihe " Priorisierung in der Medizin " umfasst Arbeits-und Forschungsberichte der DFG Forschergruppe FOR655 " Priorisierung in der Medizin: eine theoretische und empirische Analyse unter besonderer Berücksichtigung der(More)
We report results of a survey of a representative sample of the German population in which respondents were asked for their willingness-to-pay (WTP) for either an extension of their life or an improvement in their health corresponding to a gain of one quality-adjusted life year (QALY). While one version of the survey exactly copied the questionnaire used in(More)
BACKGROUND The topic of this paper is related to equity in health within a country. In public health care sectors of many countries decisions on priority setting with respect to treatment of different types of diseases or patient groups are implicitly or explicitly made. Priorities are realized by allocation decisions for medical resources where moral(More)
Personal responsibility for one’s health is frequently discussed when deciding on health-care allocation and corresponding costs. We address two questions: (1) Which health-related behavior qualifies for private contributions to treatment costs in the view of the German public? (2) Do acceptance rates for copayments depend on specific characteristics of the(More)
  • 1